Related Experiment Video

Updated: Oct 7, 2025

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.2K

Safety of Bariatric Surgery in Obese Patients With Hypertrophic Cardiomyopathy

Daokun Sun1, Hartzell V Schaff1, Travis J McKenzie2

  • 1Department of Cardiovascular Surgery.

The American Journal of Cardiology
|January 7, 2022
PubMed

Insights

Bariatric surgery for obesity in hypertrophic cardiomyopathy (HC) patients is increasingly common and safe, with no perioperative deaths or major complications observed. This procedure should be considered for obese HC patients unresponsive to conservative weight management.

Area of Science:

  • Cardiology
  • Bariatric Surgery
  • Cardiomyopathy

Background:

  • Obesity is a significant risk factor for heart failure in patients with hypertrophic cardiomyopathy (HC).
  • Understanding the trends and outcomes of bariatric surgery in this specific patient population is crucial for clinical decision-making.

Purpose of the Study:

  • To analyze national trends in bariatric surgery for obese patients with hypertrophic cardiomyopathy (HC).
  • To evaluate the early perioperative outcomes of bariatric surgery in patients with HC.

Main Methods:

  • Utilized weighted discharge data from the National Inpatient Sample (NIS) from 2011 to 2017.
  • Identified adult patients with HC undergoing elective bariatric surgery for obesity.
  • Analyzed patient demographics, comorbidities, surgical procedures, and in-hospital outcomes.

Main Results:

  • The number of bariatric surgeries in obese HC patients increased significantly from 2011 to 2017.
  • Common procedures included laparoscopic sleeve gastrectomy (72%) and Roux-en-Y gastric bypass (25%).
  • No in-hospital deaths, myocardial infarctions, or thromboembolic events were recorded; median hospital stay was 2 days.

Conclusions:

  • Bariatric surgery for obese patients with HC is increasingly performed and demonstrates a safe perioperative profile.
  • The procedure is associated with minimal early complications, suggesting it is a viable option for weight management in this cohort.
  • Clinicians should consider bariatric surgery for obese HC patients who do not achieve success with conservative weight loss strategies due to obesity's impact on survival.

More Related Videos

Sleeve Gastrectomy in Mice using Surgical Clips05:16

Sleeve Gastrectomy in Mice using Surgical Clips

Published on: November 14, 2020

6.8K
A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats07:31

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats

Published on: December 2, 2016

10.2K

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
51
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
60
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
85
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
6
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
8